Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Executive Vice President | March 03, 2026 | March 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $26.58 · Expires 2031-03-03 | Direct | 194,883 |
Reported balance
After 2026-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 194,883 · Balance 194,883 F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2026 Filed Mar 5, 2026 22:26 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 194,883 | $0.00 Strike: $26.58 | $0.00 |
DisclosureSEC source: 0001225208-26-003313 · doc4.xml · derivative · entry 1 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,883 Underlying: Common Stock · 194,883 shares Expires 2031-03-03 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 18:58 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 371,824 | $0.00 Strike: $25.75 | $0.00 |
DisclosureSEC source: 0001225208-25-003075 · doc4.xml · derivative · entry 1 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,824 Underlying: Common Stock · 371,824 shares Expires 2030-03-04 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:53 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 84,529 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-24-008702 · doc4.xml · derivative · entry 4 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,529 Underlying: Common Stock · 84,529 shares Expires 2029-02-24 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:53 UTC | PFIZER INC PFE · Entity 2863 | Disposition to issuerStock Appreciation Rights · Derivative | 84,529 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-24-008702 · doc4.xml · derivative · entry 3 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,529 shares Expires 2027-02-24 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:53 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 103,320 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-24-008702 · doc4.xml · derivative · entry 2 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,320 Underlying: Common Stock · 103,320 shares Expires 2030-02-23 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:53 UTC | PFIZER INC PFE · Entity 2863 | Disposition to issuerStock Appreciation Rights · Derivative | 103,320 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-24-008702 · doc4.xml · derivative · entry 1 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 103,320 shares Expires 2028-02-23 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| August 31, 2024 Filed Sep 3, 2024 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 20,195 | $29.01 | $585,856.95 |
DisclosureSEC source: 0001225208-24-008338 · doc4.xml · nonDerivative · entry 1 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,548 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F2 · price: Price is the closing price of Pfizer common stock on August 30, 2024. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 22:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 142,400 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001225208-24-003202 · doc4.xml · derivative · entry 2 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,400 Underlying: Common Stock · 142,400 shares Expires 2031-02-27 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 22:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 161,160 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001225208-24-003202 · doc4.xml · derivative · entry 1 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,160 Underlying: Common Stock · 161,160 shares Expires 2029-02-27 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2023 Filed Feb 25, 2023 01:45 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 89,920 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-23-002815 · doc4.xml · derivative · entry 3 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,920 Underlying: Common Stock · 89,920 shares Expires 2030-02-23 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 23, 2023 Filed Feb 25, 2023 01:45 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 103,320 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-23-002815 · doc4.xml · derivative · entry 2 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,320 Underlying: Common Stock · 103,320 shares Expires 2028-02-23 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:43 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 74,344 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003464 · doc4.xml · derivative · entry 2 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,344 Underlying: Common Stock · 74,344 shares Expires 2029-02-24 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:43 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 84,529 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003464 · doc4.xml · derivative · entry 1 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,529 Underlying: Common Stock · 84,529 shares Expires 2027-02-24 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:14 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 43,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011947 · doc4.xml · nonDerivative · entry 1 MALIK AAMIR · CIK 0001881510 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,786 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.